Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
Category: RNA (Ribonucleic Acid)
-
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
The New York Times – Business: -
Vaccine Makers Curtail Research and Cut Jobs
The New York Times – Business:Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
-
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The New York Times – Business:The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
-
F.D.A. Reviews Cases of Covid Vaccine Deaths
The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
-
Kennedy Issues Demands for Vaccine Approvals that Could Affect Fall Covid Boosters
The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether they will be available in the fall.